2013
DOI: 10.14573/altex.2013.4.411
|View full text |Cite
|
Sign up to set email alerts
|

Immunotoxicology: challenges in the 21st century and in vitro opportunities

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

1
45
0
1

Year Published

2014
2014
2023
2023

Publication Types

Select...
4
2
2

Relationship

1
7

Authors

Journals

citations
Cited by 52 publications
(47 citation statements)
references
References 106 publications
1
45
0
1
Order By: Relevance
“…ttCs were first used for carcinogens, but the concept has also been adapted to reproductive toxicity testing (van Ravenzwaay et al, 2011). We argued in a similar way in the context of immunotoxicity (Hartung and Corsini, 2013), showing that clinical immunosuppressants require mg/kg quantities to exert their effects and that this could be used for establishing ttC for substances not optimized for this purpose.…”
Section: Consideration 6: Green Toxicology As a Driver Of 21 St Centumentioning
confidence: 97%
See 1 more Smart Citation
“…ttCs were first used for carcinogens, but the concept has also been adapted to reproductive toxicity testing (van Ravenzwaay et al, 2011). We argued in a similar way in the context of immunotoxicity (Hartung and Corsini, 2013), showing that clinical immunosuppressants require mg/kg quantities to exert their effects and that this could be used for establishing ttC for substances not optimized for this purpose.…”
Section: Consideration 6: Green Toxicology As a Driver Of 21 St Centumentioning
confidence: 97%
“…Some positive examples exist, especially in the field of aquatic toxicity (Voutchkova et al, 2010a(Voutchkova et al, ,b, 2011, but this is arguably an easy case, where lipophilicity is key to uptake and thus a hazard. this does not mean, however, that helpful estimates for more complex hazards, such as immunotoxicity (Hartung and Corsini, 2013), developmental neurotoxicity (Smirnova et al, 2014) or endocrine disruption (Juberg et al, 2014), could not be done.…”
Section: Introductionmentioning
confidence: 99%
“…As these are foreign materials, such as proteins different from those of the laboratory animal species, animals will often develop (neutralising) antibodies and can even develop anaphylactic reactions if chronically treated. While traditional toxicological endpoints are of similar relevance, the immunomodulatory properties of these entities require additional focus (Hartung and Corsini, 2013). Often, production is also more difficult to standardise, requiring batch release tests (as is well known for traditional vaccines).…”
Section: New Products Not Suitable For Traditional Testsmentioning
confidence: 99%
“…Possible examples of continuously increasing health problems include atherosclerosis, male infertility and other possible manifestations of endocrine disruption, autism and other developmental behavioural disorders (Smirnova et al, 2014), immunotoxicity (Hartung and Corsini, 2013), childhood asthma and other obstructive lung diseases, obesity, and diabetes. This is not to suggest that these health problems are caused by environmental chemicals, but that their unclear etiology and, in most cases, increasing numbers, suggest the need for testing.…”
Section: New Hazards Not Coveredmentioning
confidence: 99%
“…Todavia, estudos demonstram que, em pesquisas sobre toxicidade, experiências com animais são insuficientes para fornecer benefícios substanciais que permitam o desenvolvimento de pesquisas clínicas em humanos (Knight, 2007a, Hartung andCorsini, 2013). Pesquisas sobre processo inflamatório em roedores evidenciam que os animais não são bons modelos para humanos, em estudos onde é possível comparar resultados clínicos em espécies diferentes (Leist and Hartung, 2013 (Jomaa et al, 2014).…”
Section: Estudos Toxicológicosunclassified